Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Price Movement Clarification

Corona Remedies Price Movement Clarification

CORONA Remedies Limited clarified that the recent increase in its share trading volume is purely market-driven and no undisclosed price-sensitive information exists.

Source

NSE filing, NSE: CORONA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Corona Remedies Ltd: key numbers

Share price
₹2,200.60
Market cap
₹13,459 Cr
Revenue (annual)
₹1,403 Cr
Net profit (annual)
₹185.1 Cr
P/E (TTM)
67.6×Sector 46.1×
Promoter holding
69.00%+0.00% QoQ
FII holding
4.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Corona Remedies Ltd

All →
17:54 IST BSE
Earnings Call

Corona Remedies Earnings Call Transcript: Key Takeaways

Corona Remedies reported robust Q1 FY27 results with 21.9% revenue growth and 33.5% EBITDA growth. Strategy focuses on chronic therapies and scaling brand portfolios.

Call
Guides 20% growth

Other price movement clarification announcements

All →